Please provide your email address to receive an email when new articles are posted on . Multiple pathophysiologic abnormalities contribute the development and progression of diabetic kidney disease, ...
Key opinion leaders discuss the clinical significance of dosing flexibility for the CANDOR trial regimen, as studied in the EQUULEUS trial. C. Ola Landgren, MD, PhD: The once-weekly and twice-weekly ...
One of the complications of diabetes is diabetic kidney disease (DKD), a condition in which the kidneys do not filter blood correctly and, eventually, fail — DKD is one of the most common causes of ...
In patients with diabetes, serum fibroblast growth factor 23 (FGF23) levels may be an independent biomarker for early detection of diabetic kidney disease (DKD) and may improve the predictive ...
Please provide your email address to receive an email when new articles are posted on . Topline findings from the FIDELIO-DKD study show the investigational drug finerenone delayed the progression of ...
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer’s Phase III cardiovascular outcomes study FIGARO-DKD, evaluating the efficacy and safety of the investigational drug finerenone versus placebo when added to ...
(UPDATED) For patients with type 2 diabetes and mild-to-moderate renal disease, finerenone (Bayer AG) significantly cuts the risk of major cardiovascular events, a benefit largely the result of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results